# N-Power Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/n-power-medicine

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.npowermedicine.com
- Total disclosed funding: $32M
- Latest round: Series B (Sep 1, 2026)
- Investors on record: 3

## About

Co-founded in 2021 by CEO Mark Lee, Christer Svedman, Wenn Sun, Jing He, Gary Palmer, and Angela Lai, based in California, US, N-Power Medicine, Inc. operates as a biotechnology research company that offers a clinical research platform for oncology practices and biopharma companies to develop biopharmaceuticals for treating cancer. In September 2026, N-Power Medicine, Inc. raised USD 32 million in series B funding led by LabCorp Ventures, with participation from Innovatus Capital Partners and Merck Global Health Innovation Fund. 

N-Power Medicine offers a clinical research platform designed to enhance data collection and analysis for drug development. The platform captures critical patient data not found in EMRs, aiding in patient cohort refinement, biomarker identification, and clinical endpoint validation. It integrates diverse data sources and standardizes information through the Kaleido™ Registry, improving clinical trial feasibility and operational performance. N-Power supports oncology clinics with on-site and virtual staff, enabling efficient data collection and clinical trial management. Their solutions also include real-time patient recruitment and enrollment, advanced data analytics, and comprehensive clinical trial support, ultimately aiming to accelerate drug development and improve patient outcomes.

The company intends to use the September 2026 funding to expand its community oncology research network, increase adoption of its ProECA platform, and continue product development.

## Funding rounds

- Series B, Sep 1, 2026, $32M — Merck Global Health Innovation Fund, Innovatus Capital Partners, LabCorp Ventures

## Investors

- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B
- Innovatus Capital Partners (https://capitalatlas.ai/funds/innovatus-capital-partners) — Series B
- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series B